Supernus Pharmaceuticals Inc.

01/28/2026 | Press release | Distributed by Public on 01/28/2026 16:29

Material Agreement (Form 8-K)

Item 1.01 Entry into a Material Definitive Agreement.
On January 22, 2026, Supernus Pharmaceuticals, Inc. (the "Company") entered into a First Amendment (the "Amendment") to the Agreement and Plan of Merger dated September 12, 2018 (the "Merger Agreement"), with Reich Consulting Group, Inc. as the Securityholder Representative.
The Amendment relates to the timing and payment of certain milestones under the Merger Agreement.
The foregoing description is qualified in its entirety by reference to the full text of the Amendment, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Supernus Pharmaceuticals Inc. published this content on January 28, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on January 28, 2026 at 22:29 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]